Danshan Gu

机构：Kunming Medical University

发表论文 6 篇 · 总被引 216 次 · h-index 6

代表论文

• Ginsenoside Rg1 Regulates Liver Lipid Factor Metabolism in NAFLD Model Rats (2020 · ACS Omega · 被引 55)
• Ginsenoside Rg1 attenuates hepatic insulin resistance induced by high-fat and high-sugar by inhibiting inflammation (2019 · European Journal of Pharmacology · 被引 52)
• Investigations on the effects of ginsenoside-Rg1 on glucose uptake and metabolism in insulin resistant HepG2 cells (2018 · European Journal of Pharmacology · 被引 46)
• Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease (2020 · Life Sciences · 被引 32)
• Scutellarin Reduce the Homocysteine Level and Alleviate Liver Injury in Type 2 Diabetes Model (2020 · Frontiers in Pharmacology · 被引 23)
• Differentially expressed haptoglobin as a potential biomarker for type 2 diabetic mellitus in Hispanic population (2017 · BioFactors · 被引 7)